Back to Results
First PageMeta Content

Noven Enters Co-Promotion Agreement with Shionogi for Brisdelleā„¢ (Paroxetine) Capsules Co-Promotion to Extend Physician Awareness of the First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Menopa
Add to Reading List

Document Date: 2014-01-13 09:33:45

Open Document

File Size: 266,64 KB

Share Result on Facebook